J&J Talc Verdict Spells Opportunity For Plaintiffs, Talc-Free Powder Market
This article was originally published in The Rose Sheet
Executive Summary
Johnson & Johnson is working to assure consumers of talc safety following a St. Louis jury verdict ordering the company to pay $72m in damages to the family of a late Alabama woman who attributed her ovarian cancer to perineal use of the company's baby and body powders. Around 1,200 similar cases are pending against the company in Missouri and New Jersey courts.
You may also be interested in...
Cue The Class Actions! Plaintiffs React To Valisure’s Benzene Findings In Acne Drug Products
J&J, Target and Walgreens face class action complaints in California federal courts for economic harms caused by their sale of benzoyl peroxide-containing acne treatments, following Valisure’s 5 March citizen petition to the US FDA on findings of high levels of benzene in such products.
J&J Wins Reversal Of $72M Talc Verdict, Signaling Whole New Ballgame
What has seemed an endless queue of plaintiffs waiting to litigate claims against J&J in Missouri for alleged talc harm may begin thinning out following a June mistrial and now the reversal of an earlier $72m verdict against the company, both due to jurisdictional issues dictated by a recent Supreme Court ruling.
Cosmetic News In Brief: J&J Loses Fourth Talc Trial; California Salon Labeling Bill; More
In the biggest talc verdict to date, J&J is ordered to pay $110m to a woman who alleges a link between use of the firm’s Johnson’s Baby Powder and ovarian cancer, the fourth such loss for the firm in the same St. Louis court; More cosmetics news in brief.